Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial
Clinical trial NCT03588741 · TERMINATED
Trial details
- NCT number
- NCT03588741
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2019-06-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.